For instance, DVL1 concentrations were significantly different between pancreatic and lung NETs (p < 0.05), suggesting that the molecular mechanisms involving DVL1 in pancreatic NETs might differ from those in lung NETs. The gene discussed is DVL1; the disease is pancreatic neuroendocrine tumor.